LASSO NTCP predictors for the incidence of xerostomia in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Lee, Tsair Fwu ^a   Liou, Ming Hsiang ^a,b   Huang, Yu Jie ^c   Chao, Pei Ju ^a,c   Ting, Hui Min ^a,c   Lee, Hsiao Yi ^a   Fang, Fu Min ^c  

^a NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^b YUAN'S GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; PROBABILITY; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION INJURIES; VERY ELDERLY; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; PROBABILITY; QUALITY OF LIFE; QUESTIONNAIRES; RADIATION INJURIES; XEROSTOMIA;

EID: 84906815268     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06217     Document Type: Article

References (33)

1. Beetz, I. et al. External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy. Radiother Oncol 105, 94-100 (2012).
2. Lee, T.-F. & Fang, F.-M. Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy. Radiother Oncol 106, 352-358 (2013).
3. Bensouda, Y. et al. Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis 128, 79-85 (2011).
4. Barnes, L., Organization, W. H. & Cancer, I. A. f. R. o. Pathology and genetics of head and neck tumours. (World Health Organization, 2005).
5. Bonner, J. A. et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354, 567-578, doi:10.1056/ NEJMoa053422 (2006).
6. Perez, C. A. et al. Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys 23, 271-280 (1992).
7. Halperin, E. C., Brady, L. W., Wazer, D. E. & Perez, C. A. Perez & Brady's Principles and Practice of Radiation Oncology. (Lippincott Williams & Wilkins, 2013).
8. Beetz, I. et al. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: The role of dosimetric and clinical factors. Radiother Oncol 105, 101-106 (2012).
9. Beetz, I. et al. The QUANTEC criteria for parotid gland dose and their efficacy to prevent moderate to severe patient-rated xerostomia. Acta Oncologica, 1-8 (2013).
10. Lee, T.-F. et al. Using Multivariate Regression Model with Least Absolute Shrinkage and Selection Operator (LASSO) to Predict the Incidence of Xerostomia after Intensity-Modulated Radiotherapy for Head and Neck Cancer. PLoS ONE 9, 1-11; e89700, doi:10.1371/journal.pone.0089700 (2014).
11. Lee, T.-F. et al. Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments. BMC cancer 12, 567 (2012).
12. Xu, C.-J., van der Schaaf, A., Schilstra, C., Langendijk, J. A. & van't Veld, A. A. Impact of statistical learning methods on the predictive power of multivariate normal tissue complication probability models. Int J Radiat Oncol Biol Phys 82, e677-e684 (2012).
13. Xu, C.-J., van der Schaaf, A., Van't Veld, A. A., Langendijk, J. A. & Schilstra, C. Statistical validation of normal tissue complication probability models. Int J Radiat Oncol Biol Phys 84, e123-e129 (2012).
14. Xu, J. & Yin, J. Kernel least absolute shrinkage and selection operator regression classifier for pattern classification. Comput Vis, IET 7, 48-55 (2013).
15. De Ruyck, K. et al. Development of amulticomponent prediction model for acute esophagitis in lung cancer patients receiving chemoradiotherapy. Int J Radiat Oncol Biol Phys 81, 537-544 (2011).
16. Beetz, I. et al. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: The role of dosimetric and clinical factors. Radiother Oncol 105, 86-93 (2012).
17. El Naqa, I. et al. Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors. Int J Radiat Oncol Biol Phys 64, 1275-1286 (2006).
18. van de Water, T. A., Bijl, H. P., Westerlaan, H. E. & Langendijk, J. A. Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia. Radiother Oncol 93, 545-552 (2009).
19. Lyman, J. T. Complication probability as assessed from dose-volume histograms. Radiat Res 104, S13-S19 (1985).
20. Skwarchuk, M. W. et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 47, 103-113 (2000).
21. Ramsey, S. D. et al. Quality of life in survivors of colorectal carcinoma. Cancer 88, 1294-1303 (2000).
22. Fang, F.-M. et al. Multivariate analysis of quality of life outcome for nasopharyngeal carcinoma patients after treatment. Radiother Oncol 97, 263-269 (2010).
23. Miah, A. B. et al. Dose-response analysis of parotid gland function: What is the best measure of xerostomia? Radiother Oncol 106, 341-345 (2013).
24. Kam, M. K. et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clini Oncol 25, 4873-4879 (2007).
25. Moiseenko, V. et al. Treatment planning constraints to avoid xerostomia in headand-neck radiotherapy: an independent test of QUANTEC criteria using a prospectively collected dataset. Int J Radiat Oncol Biol Phys 82, 1108-1114 (2012).
26. Deasy, J. O. et al. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 76, S58-S63 (2010).
27. Kim, D. R. et al. A predictive model for dysphagia following IMRT for head and neck cancer: Introduction of the EMLasso technique. Radiother Oncol 107, 295-299 (2013).
28. Marucci, L. et al. Influence of intensity-modulated radiation therapy technique on xerostomia and related quality of life in patients treated with intensity-modulated radiation therapy for nasopharyngeal cancer. Head Neck-J Sci Spec 34, 328-335, doi:10.1002/hed.21736 (2012).
29. Lee, T.-F., Ting, H.-M., Chao, P.-J. & Fang, F.-M. Dual Arc volumetric-modulated Arc radiotherapy (VMAT) of nasopharyngeal carcinomas: a simultaneous integrated boost treatment plan comparison with intensity-modulated radiotherapies and single arc VMAT. Clini Oncol 24, 196-207 (2012).
30. Leung, S. W. & Lee, T.-F. Treatment of nasopharyngeal carcinoma by tomotherapy: five-year experience. BMC Cancer 5, 9, 1-9 (2013).
31. Chen, W.-C. et al. Scintigraphic assessment of salivary function after intensitymodulated radiotherapy for head and neck cancer: Correlations with parotid dose and quality of life. Oral Oncol 49, 42-48 (2013).
32. Tibshirani, R. Regression shrinkage and selection via the lasso. J Roy Stat Soc B 267-288 (1996).
33. Hastie, T., Tibshirani, R., Friedman, J. & Franklin, J. The elements of statistical learning: data mining, inference and prediction. The Math Intellg 27, 83-85 (2005).